RenovionJan 112 minNon-CF Bronchiectasis Renovion Completes Enrollment of Adult Patients in Phase 2 CLIMB Study in BronchiectasisRenovion Inc., a company focused on restoring lung health in patients with bronchiectasis, announces patient enrollment for Phase 2 trial.
RenovionNov 2, 20223 minNon-CF Bronchiectasis First Patient Enrolled in Phase 2 Clinical Study Evaluating ARINA-1 for the Treatment of NCFBERenovion and COPD Foundation Joint Release – Renovion, Inc. has announced that the first patient has been enrolled in a Phase 2 clinical...
RenovionApr 7, 20222 minNon-CF Bronchiectasis Renovion Provides Regulatory Update and Initiation of Clinical Program in Non-CF BronchiectasisRenovion, Inc., a clinical-stage pharmaceutical company focused on developing treatments for rare, chronic, and serious lung diseases...